Biggest News Aggregation in the World
📰 Beigene News

Page 21 - Beigene News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Beigene. Real-time updates on events, politics, business and more.

Big Pharma must sacrifice upfront profits to get on China's coveted list of medicines eligible for insurance reimbursements

The NRDL, a compilation that has existed for two decades, is part of the Chinese government’s plan to make health care affordable and accessible under the country’s socialist principles. Formally adopted in 2017 as an annual list, it forms part of the “common prosperity” aspiration pledged by President Xi Jinping.
Hong Kong City Of United Kingdom Innovent Biologics Zhangzhou Pientzehuang Bristol Myer Squibb Juno
Source: scmp.com

Fierce Pharma Asia—Merck, Eisai's failed Lenvima trial; J&J, Legend's CAR-T data; AstraZeneca-Samsung COVID pact

Merck and Eisai's Lenvima failed a Keytruda combo trial in newly diagnosed lung cancer. Johnson & Johnson and Legend Biotech's CAR-T posted a long tail to disease progression. AstraZeneca and Samsung Biologics included AZ's COVID antibody in their contract manufacturing deal. And more.
United States Samsung Biologics Bristol Myers Squibb Abecma Astella Xospata Eli Lilly Bristol Myers Squibb Vidaza

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science